New nucleic acid useful as immuno-stimulating adjuvant for manufacture of a composition for treatment of cancer diseases e.g. colon carcinomas and infectious diseases e.g. influenza and malaria

摘要

Nucleic acid (I) is new. Nucleic acid of formula G lX mG n (I) is new. G = guanosine, uracil or an analog; X = guanosine, uracil, adenosine, thymidine, cytosine or an analog; l = 1-40; m = 3; and n = 1-40. Provided that: (a) when l = 1 than G is guanosine or an analog; (b) when l 1 than at least 50% of the nucleotides are guanosine or an analog; (c) when m = 3 than X is uracil or an analog; (d) when m 3 than X carries at least 3 successive uracils or analogs; (e) when n = 1 than G is guanosine or an analog; (f) when n 1 than at least 50% of the nucleotides are guanosine or an analog. ACTIVITY : Immunostimulant; Antimicrobial; Cytostatic; Virucide; Antimalarial; Respiratory-Gen; Anti-HIV; Antibacterial; Protozoacide; Neuroprotective; Dermatological; Antiinflammatory; Immunosuppressive; Anti-Abortive; Gastrointestinal-Gen; Vulnerary; Gynecological; Osteopathic; Antileprotic; Auditory; Antiarthritic; Ophthalmological; Uropathic; Antitubercular; Tuberculostatic; Antiparasitic; Fungicide; Schistosomacide; Anthelmintic. MECHANISM OF ACTION : None given.